APREA THERAPEUTICS INC
Reported by OLD POINT TRUST & FINANCIAL SERVICES N A
Reported 0 shares, down 50 (100.0%) from the prior quarter.
Reported value -100.0%; share count -100.0% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2024-03-31 | 335 |
| 2024-06-30 | 0 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
Who else reported the position
30 managers reported APREA THERAPEUTICS INC for Q2 2024.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| AIGH Capital Management LLC | Unchanged | 539,300 | 0 | 0.68% | $2,194,951 | 6 qtrs |
| Sio Capital Management LLC | Unchanged | 276,603 | 0 | 0.3% | $1,125,774 | 6 qtrs |
| SPHERA FUNDS MANAGEMENT LTD | Unchanged | 270,000 | 0 | 0.15% | $1,098,900 | 2 qtrs |
| Nantahala Capital Management LLC | Unchanged | 205,760 | 0 | 0.05% | $837,443 | 2 qtrs |
| Altium Capital Management LP | New | 137,197 | +137,197 | 0.23% | $558,392 | 1 qtr |
| DAFNA Capital Management LLC | Unchanged | 137,174 | 0 | 0.13% | $558,298 | 2 qtrs |
| Exome Asset Management LLC | New | 137,174 | +137,174 | 0.5% | $558,298 | 1 qtr |
| Stonepine Capital Management LLC | New | 137,174 | +137,174 | 0.51% | $558,298 | 1 qtr |
| VANGUARD GROUP INC | Reduced | 115,838 | -140 | < 0.01% | $471,461 | 6 qtrs |
| GEODE CAPITAL MANAGEMENT LLC | Added | 35,673 | +15,452 | < 0.01% | $145,215 | 5 qtrs |
Filing details and methodology As reported
- Report period
- June 30, 2024
- Filed
- August 13, 2024
- Filing type
- 13F-HR
- Position type
- Com
Voting authority reported
No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.